Voxvoganan (LTX-109, Lytixar) is an experimental antibiotic medication for topical use. It is a synthetic peptide which is in clinical trials against skin infections caused by drug-resistant strains of Staphylococcus aureus.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.